FSRH CEU Statement: Response to new study by Meaidi et al (September 2023)

a3c46a8228deeb3bababd4988525a759

Published on: 7 September 2023

File size: 433kb PDF

File type: Clinical Statements

This FSRH Statement responses to a recently published study by Meaidi et al. published on 06/09/2023 which used data from nationwide Danish databases to compare risk of first VTE events during use of hormonal contraception (HC) with that during concomitant use of HC and the non-steroidal anti-inflammatory drugs (NSAIDs) ibuprofen, diclofenac or naproxen.

Your download should start automatically. If not download directly.